Document is current
Any future updates will be listed below
-
Authors
Wu, Yiqian https://orcid.org/0000-0002-6313-6015
Huang, Ziliang https://orcid.org/0000-0002-4102-3300
Liu, Yahan
He, Peixiang
Wang, Yuxuan
Yan, Liyanran
Wang, Xinhui
Gao, Shanzi
Zhou, Xintao
Yoon, Chi Woo
Sun, Kun https://orcid.org/0000-0002-9883-1616
Situ, Yinglin https://orcid.org/0009-0007-3810-2626
Ho, Phuong
Zeng, Yushun https://orcid.org/0000-0001-5995-4085
Yuan, Zhou
Zhu, Linshan
Zhou, Qifa https://orcid.org/0000-0003-1527-3020
Zhao, Yunde https://orcid.org/0000-0002-7224-8449
Liu, Thomas
Kwong, Gabriel A.
Chien, Shu https://orcid.org/0000-0003-0332-285X
Liu, Longwei https://orcid.org/0000-0003-4229-9066
Wang, Yingxiao https://orcid.org/0000-0003-0265-326X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (EB029122, GM140929, HL121365, HD107206, CA262815, EB032822, K01EB035649)
- License Information
-
More Information
Article History
Received: 23 January 2024
Accepted: 11 November 2024
First Online: 1 December 2024
Competing interests
: Y. Wang is a scientific co-founder and consultant of Cell E&G Inc. and Acoustic Cell Therapy Inc. These financial interests do not affect the design, conduct, or reporting of this research. G.K. is a co-founder of Glympse Bio and Port Therapeutics. This study could affect his personal financial status. The terms of this arrangement have been reviewed and approved by Georgia Tech in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.
